These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24668159)

  • 1. A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.
    Kumar R; Smith RE; Henry BL
    J Intensive Care Med; 2015 Dec; 30(8):462-72. PubMed ID: 24668159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
    Ross B; Miller MA; Ditch K; Tran M
    J Med Toxicol; 2014 Jun; 10(2):223-8. PubMed ID: 24385325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran use in elderly patients with atrial fibrillation.
    Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
    Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran in nonvalvular atrial fibrillation: from clinical trials to real-life experience.
    Mumoli N; Mastroiacovo D; Tamborini-Permunian E; Vitale J; Giorgi-Pierfranceschi M; Cei M; Dentali F
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):467-477. PubMed ID: 28509761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
    Pahs L; Beavers C; Schuler P
    Crit Pathw Cardiol; 2015 Jun; 14(2):53-61. PubMed ID: 26102014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
    Milling TJ; Fromm C; Ganetsky M; Pallin DJ; Cong J; Singer AJ
    Ann Emerg Med; 2017 May; 69(5):531-540. PubMed ID: 28196608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
    Marino KK; Santiago RA; Dew RB; Berliner N; Connors JM; Connell NT; Tucker JK
    Pharmacotherapy; 2016 Oct; 36(10):e160-e165. PubMed ID: 27581709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.
    Weitz JI; Pollack CV
    Thromb Haemost; 2015 Nov; 114(6):1113-26. PubMed ID: 26155974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran Use in the Real World: A Multihospital System Experience.
    Kimmons LA; Kabra R; Davis M; Segars BV; Oliphant CS
    J Pharm Pract; 2014 Aug; 27(4):384-8. PubMed ID: 24319080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing the anticoagulation effects of dabigatran.
    Dager WE; Banares L
    Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dabigatran-associated bleeding: case report and review of the literature.
    Harinstein LM; Morgan JW; Russo N
    J Pharm Pract; 2013 Jun; 26(3):264-9. PubMed ID: 23160864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
    Kolb JM; Flack KF; Chatterjee-Murphy P; Desai J; Wallentin LC; Ezekowitz M; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
    Dig Dis Sci; 2018 Jul; 63(7):1878-1889. PubMed ID: 29582237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L; Chen C; White J
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
    Abe J; Umetsu R; Kato Y; Ueda N; Nakayama Y; Suzuki Y; Suzuki T; Nagasawa H; Kinosada Y; Nakamura M
    Int J Med Sci; 2015; 12(4):312-21. PubMed ID: 25897292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A; Baranchuk A; Redfearn D; Simpson C; Abdollah H; Michael K
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):529-40. PubMed ID: 25843430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed.
    Milling TJ; Spyropoulos AC
    Am J Emerg Med; 2016 Nov; 34(11S):19-25. PubMed ID: 27697440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.
    Reilly PA; van Ryn J; Grottke O; Glund S; Stangier J
    Am J Med; 2016 Nov; 129(11S):S64-S72. PubMed ID: 27569674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.